Neck mass as a consequence of surgical implantation of cervical chordoma: A case report

Yıl 2018, Cilt: 28 Sayı: 4, 192 - 197, 18.12.2018

Zekiye Kabaş Uysal Bekir Tatar Demet Etit Yusuf Çağdaş Kumbul

Öz

Chordoma is a rare primary malignant tumor of notochord origin along the craniospinal axis. Extranotochordal chordoma is extremely rare. These slow-growing but highly destructive tumors have worrisome local recurrence rates following successful primary treatment. Symptoms and findings are due to localization of the lesion. The primary treatment option is surgery because of weak chemotherapy and radiotherapy response. The size of surgical resection in these tumors has a major effect in ensuring disease-free surveillance. Recurrence throughout the surgical site is a rare form of treatment failure. A case of cervical chordoma diagnosis and chordoma recurrence on follow-up is presented in this study because of its rare clinical course.

Anahtar Kelimeler

Chordoma, implantation, neck, surgery

Kaynakça

• 1. Russell DS, Rubinstein LJ. Tumours and tumuor-like lesions of mal developmental origin. In: Pathology of Tumors of the Nervous System. 5th ed. London: Edward Arnold; 1989. p. 664-765.
• 2. Nishigaya K, Kaneko M, Ohashi Y, Nukui H. Intradural retroclival chordoma without bone involvement: no tumor regrowth 5 years after operation. Case report. J Neurosurg 1998;88:764-8.
• 3. Sze G, Uichanco LS, Brant-Zawadzki MN, Davis RL, Gutin PH, Wilson CB, et al. Chordomas: MR imaging. Chordomas: MR imaging. Radiology 1988;166:187-91.
• 4. al-Mefty O, Borba LA, Aoki N, Angtuaco E, Pait TG. The transcondylar approach to extradural nonneoplastic lesions of the craniovertebral junction. J Neurosurg 1996;84:1-6.
• 5. Gay E, Sekhar LN, Rubinstein E, Wright DC, Sen C, Janecka IP, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995;36:887-96.
• 6. al-Mefty O, Borba LA. Skull base chordomas: a management challenge. J Neurosurg 1997;86:182-9.
• 7. Colli BO, Al-Mefty O. Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus 2001;10:1.
• 8. Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O'Fallon JR, Dozier JC, et al. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 1993;78:741-7.
• 9. Fischbein NJ, Kaplan MJ, Holliday RA, Dillon WP. Recurrence of clival chordoma along the surgical pathway. AJNR Am J Neuroradiol 2000;21:578-83.
• 10. Boyette JR, Seibert JW, Fan CY, Stack BC Jr. The etiology of recurrent chordoma presenting as a neck mass: metastasis vs. surgical pathway seeding. Ear Nose Throat J 2008;87:106-9.
• 11. Stacchiotti S, Gronchi A, Fossati P, Akiyama T, Alapetite C, Baumann M, et al. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann Oncol 2017;28:1230-42.
• 12. Cloyd JM, Acosta FL Jr, Polley MY, Ames CP. En bloc resection for primary and metastatic tumors of the spine: a systematic review of the literature. Neurosurgery 2010;67:435-44.
• 13. Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 2010;17:211-9.
• 14. Arnautović KI, Al-Mefty O. Surgical seeding of chordomas. J Neurosurg 2001;95:798-803.
• 15. Kinoshita T, Okudera T, Shimosegawa E, Yoshida Y, Yasui N, Ogawa T, et al. Chordoma with postoperative subcutaneous implantation and meningeal dissemination: MRI. Neuroradiology 2001;43:763-6.
• 16. Samii A, Gerganov VM, Herold C, Hayashi N, Naka T, Mirzayan MJ, et al. Chordomas of the skull base: surgical management and outcome. J Neurosurg 2007;107:319-24.
• 17. McDonald MW, Linton OR, Shah MV. Proton therapy for reirradiation of progressive or recurrent chordoma. Int J Radiat Oncol Biol Phys 2013;87:1107-14.
• 18. Wagner TD, Kobayashi W, Dean S, Goldberg SI, Kirsch DG, Suit HD, et al. Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. Int J Radiat Oncol Biol Phys 2009;73:259-66.